Trimodality therapy for superior sulcus tumours: Evolution and evaluation of a treatment protocol

European Journal of Surgical Oncology

Volumn 39, Issue 2, 2013, Pages 197-203

  Vos, C G ^a   Hartemink, K J ^a   Blaauwgeers, J L G ^a   Oosterhuis, J W A ^a   Senan, S ^a   Smit, E F ^a   Thunnissen, E ^a   Paul, M A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Outcome; Pancoast; Superior sulcus tumour; Survival; Trimodality treatment

Indexed keywords

CISPLATIN; ETOPOSIDE; GEMCITABINE; PEMETREXED;

ADULT; AGED; ARTICLE; ATELECTASIS; BRAIN METABOLISM; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL PROTOCOL; COHORT ANALYSIS; EMPYEMA; ESOPHAGITIS; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HUMAN; KYPHOSCOLIOSIS; LEUKOPENIA; LUNG EMBOLISM; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEURALGIA; NEUTROPENIA; OTOTOXICITY; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPINAL CORD COMPRESSION; TUMOR RECURRENCE; WOUND INFECTION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMORADIOTHERAPY; CISPLATIN; ETOPOSIDE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; THORACOTOMY; TRACHEOSTOMY; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84872123251     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.09.002     Document Type: Article

References (16)

1. W.M. Alberts American College of Chest Physicians Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 2007 1S 19S (Pubitemid 47502795)
2. V.W. Rusch, D.J. Giroux, and M.J. Kraut Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160) J Clin Oncol 25 2007 313 318 (Pubitemid 350003020)
3. H. Kunitoh, H. Kato, M. Tsuboi Japan Clinical Oncology Group Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group Trial 9806 J Clin Oncol 26 2008 644 649 (Pubitemid 351264361)
4. I. Kappers, J.W. van Sandick, and J.A. Burgers Results of combined modality treatment in patients with non-small-cell lung cancer of the superior sulcus and the rationale for surgical resection Eur J Cardiothorac Surg 36 2009 741 746
5. J. Li, C.H. Dai, S.B. Shi, Q.L. Bao, L.C. Yu, and J.R. Wu Induction concurrent chemoradiotherapy compared with induction radiotherapy for superior sulcus non-small cell lung cancer: a retrospective study Asia Pac J Clin Oncol 6 2010 57 65
6. K.F. Kwong, M.J. Edelman, and M. Suntharalingam High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survival J Thorac Cardiovasc Surg 129 2005 1250 1257 (Pubitemid 40804841)
7. A. Marra, W. Eberhardt, and C. Pöttgen Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour Eur Respir J 29 2007 117 126
8. N. Pourel, N. Santelmo, and N. Naafa Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response Eur J Cardiothorac Surg 33 2008 829 836
9. K.R. Shen, B.F. Meyers, J.M. Larner, D.R. Jones American College of Chest Physicians Special treatment issues in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition) Chest 132 2007 290S 305S (Pubitemid 47502814)
10. E. Vallières, F.A. Shepherd, J. Crowley International Association for the Study of Lung Cancer International Staging Committee and Participating Institutions The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer J Thorac Oncol 4 2009 1049 1059
11. E.C. Phernambucq, F.O. Spoelstra, and M.A. Paul Evaluation of a treatment strategy for optimising preoperative chemoradiotherapy in stage III non-small-cell lung cancer Eur J Cardiothorac Surg 36 2009 1052 1057
12. K.W. Maas, S.Y. El Sharouni, and E.C. Phernambucq Weekly chemoradiation (docetaxel/cisplatin) followed by surgery in stage III NCSLC; a multicenter phase II study Anticancer Res 30 2010 4237 4243
13. R.J. Cerfolio, A.S. Bryant, T.S. Winokur, B. Ohja, and A.A. Bartolucci Repeat FDG-PET after neoadjuvant therapy is a predictor of pathologic response in patients with non-small cell lung cancer Ann Thorac Surg 78 2004 1903 1909 (Pubitemid 39556258)
14. C.J. Hoekstra, S.G. Stroobants, and E.F. Smit Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer J Clin Oncol 23 2005 8362 8370
15. G.R. Borst, J.S.A. Belderbos, and R. Boellaard Standardised FDG uptake: a prognostic factor for inoperable non-small cell lung cancer Eur J Cancer 41 2005 1533 1541 (Pubitemid 40981834)
16. S.M. Eschmann, G. Friedel, and F. Paulsen 18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer Eur J Nucl Med Mol Imaging 34 2007 463 471 (Pubitemid 46426996)